SearcharxivSearch

arXiv subjects

Adrien Grenier

Publications and source records attributed to Adrien Grenier.

3 recordsLinked to original sources

NewPINNs: Physics-Informing Neural Networks Using Conventional Solvers for Partial Differential Equations

We introduce NewPINNs, a physics-informing learning framework that couples neural networks with conventional numerical solvers for solving differential equations. Rather than enforcing governing equations and boundary conditions through residual-based loss terms, NewPINNs integrates the solver directly into the training loop and defines learning objectives through solver-consistency. The neural network produces candidate solution states that are advanced by the numerical solver, and training minimizes the discrepancy between the network prediction and the solver-evolved state. This pull-push interaction enables the network to learn physically admissible solutions through repeated exposure to the solver's action, without requiring problem-specific loss engineering or explicit evaluation of differential equation residuals. By delegating the enforcement of physics, boundary conditions, and numerical stability to established numerical solvers, NewPINNs mitigates several well-known failure modes of standard physics-informed neural networks, including optimization pathologies, sensitivity to loss weighting, and poor performance in stiff or nonlinear regimes. We demonstrate the effectiveness of the proposed approach across multiple forward and inverse problems involving finite volume, finite element, and spectral solvers.

cs.LG

Knockdown of human AMPK using the CRISPR-Cas9 genome-editing system

AMP activated protein kinase (AMPK) is a critical energy sensor, regulating signaling networks involved in pathology including metabolic diseases and cancer. This increasingly recognized role of AMPK has prompted tremendous research efforts to develop new pharmacological AMPK activators. To precisely study the role of AMPK, and the specificity and activity of AMPK activators in cellular models, genetic AMPK inactivating tools are required. We report here methods for genetic inactivation of AMPK $\alpha1/ \alpha2$ catalytic subunits in human cell lines by the CRISPR/Cas9 technology, a recent breakthrough technique for genome editing.

q-bio.OT